Poly Medicure Limited (BOM: 531768)
India
· Delayed Price · Currency is INR 2,696.20
+42.25 (1.59%)
At close: Nov 14, 2024
Poly Medicure Revenue
Poly Medicure had revenue of 4.20B INR in the quarter ending September 30, 2024, with 24.52% growth. This brings the company's revenue in the last twelve months to 15.22B, up 21.82% year-over-year. In the fiscal year ending March 31, 2024, Poly Medicure had annual revenue of 13.76B with 23.36% growth.
Revenue (ttm)
15.22B
Revenue Growth
+21.82%
P/S Ratio
17.05
Revenue / Employee
2.42M
Employees
6,300
Market Cap
273.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 13.76B | 2.61B | 23.36% |
| Mar 31, 2023 | 11.15B | 1.92B | 20.82% |
| Mar 31, 2022 | 9.23B | 1.37B | 17.37% |
| Mar 31, 2021 | 7.86B | 992.31M | 14.44% |
| Mar 31, 2020 | 6.87B | 764.14M | 12.51% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPoly Medicure News
- 20 days ago - Poly Medicure Q2 Results: Revenue surges 9.15% YoY to ₹420.01 crore, Net Profit surges 40.64% YoY - Business Upturn
- 20 days ago - Stock market update: Q2 FY25 results today for Sumitomo Chemical, Pfizer, Poly Medicure, Firstsource, Anant Raj, CAMS, Kalpatru, Railtel and more - Business Upturn
- 4 weeks ago - Top gainers in today’s market: Aptus surges 9.20%, BSE up 7.80%, Poly Medicure jumps 6.24%, CDSL rises 5.26% - Business Upturn
- 3 months ago - Poly Medicure shares rise nearly 2% after raising ₹1,000 crore through QIP - Business Upturn
- 3 months ago - Stock to watch today: Poly Medicure launches QIP to raise ₹1,000 crore - Business Upturn